Nurix Therapeutics Inc.

NRIX | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.41

-$0.03 (-0.12%)

At close: Sep 21, 2026, 4:00 PM ET

$25.40

-$0.01 (-0.04%)

Pre-market: Sep 22, 2026, 5:28 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Nov 29, 2025	FY 2024 Nov 29, 2024	FY 2023 Nov 29, 2023	FY 2022 Nov 29, 2022	FY 2021 Nov 29, 2021	FY 2020 Nov 29, 2020
Net Income	-264.46M	-193.57M	-143.95M	-180.36M	-117.19M	-43.24M
Depreciation & Amortization	18.86M	16.43M	13.65M	10.81M	6.08M	2.18M
Stock-Based Compensation	37.97M	33.93M	33.67M	28.13M	15.8M	4.3M
Other Working Capital	-30.97M	-23.61M	18.51M	-25.11M	6.75M	46.52M
Other Non-Cash Items	-10.23M	-10.97M	-4.87M	636K	1.83M	273K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-31.6M	-18.4M	20.12M	-19.02M	9.11M	36.41M
Operating Cash Flow	-249.47M	-172.58M	-81.37M	-159.81M	-84.37M	-80K
Capital Expenditures	-14M	-9.27M	-8.4M	-12.24M	-5.66M	-4.55M
Cash Acquisitions	n/a	n/a	n/a	-39.44M	102.59M	249.85M
Purchase of Investments	-455.69M	-707.95M	-246.33M	-239.37M	-348.5M	-275.22M
Sales Maturities Of Investments	617.54M	459.51M	323.04M	278.81M	245.91M	25.37M
Other Investing Acitivies	n/a	n/a	n/a	39.44M	-102.59M	-249.85M
Investing Cash Flow	147.85M	-257.71M	68.3M	27.2M	-108.25M	-254.4M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-7K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	7.17M	n/a	97.79M	3.73M	963K
Financial Cash Flow	238.64M	485.67M	3.22M	117.19M	153.88M	339.02M
Net Cash Flow	137.03M	55.37M	-9.85M	-15.42M	-38.73M	84.54M
Free Cash Flow	-263.47M	-181.86M	-89.77M	-172.05M	-90.03M	-4.63M
Adj. Free Cash Flow	-301.43M	-215.79M	-123.44M	-200.18M	-105.83M	-8.93M
Maintenance CapEx	n/a	-9.27M	n/a	-8.24M	-1.52M	-4.55M
Growth CapEx	-14M	n/a	-8.4M	-4M	-4.14M	n/a
Owner Earnings	-249.47M	-181.86M	-81.37M	-168.05M	-85.89M	-4.63M